Medicare billing address
CMS Medicare provider billing file
175 Meadowbrook LnDuncansville, PA 16635
CMS public data · NPI 1205834397
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Frederick T Murphy, DO
Specialty
Credential
DO
NPI
1205834397
Primary source state
PA
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Frederick T Murphy, DO from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
175 Meadowbrook LnCMS Doctors & Clinicians file
175 Meadowbrook LnCMS Doctors & Clinicians file
2000 Westinghouse DrCMS Doctors & Clinicians file
336 Bloomfield StIn the 2024 CMS provider billing file, this NPI had 839 Medicare beneficiaries and 132,459 total services. The average beneficiary age was 73, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$2,048,484.04
Total Medicare payment amount
$1,625,225.38
Medicare beneficiaries
839
Total services
132,459
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Osteoporosis
29%
CMS beneficiary-panel share
Anxiety
29%
CMS beneficiary-panel share
Ischemic heart disease
27%
CMS beneficiary-panel share
Diabetes
24%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 76,000 | $4.57 |
| Injection, methylprednisolone acetate, 1 mg | 6,680 | $0.13 |
| Injection, denosumab, 1 mg | 5,700 | $25.57 |
| Injection, golimumab, 1 mg, for intravenous use | 5,500 | $11.55 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,800 | $42.56 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,377 | $7.53 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 1,345 | $4.14 |
| Insertion of needle into vein for collection of blood sample | 1,334 | $8.63 |
| Measurement c-reactive protein for detection of infection or inflammation | 1,302 | $5.03 |
| Blood creatinine level | 1,261 | $4.97 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1205834397. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 1,363 | 3,671.7 | $73,422.91 |
| 2 | Methotrexate | Methotrexate Sodium | 989 | 2,456.1 | $37,779.19 |
| 3 | Tramadol Hcl | Tramadol Hcl | 755 | 764.5 | $5,986.81 |
| 4 | Prednisone | Prednisone | 709 | 1,699.2 | $5,229.78 |
| 5 | Methylprednisolone | Methylprednisolone | 373 | 807.9 | $7,461.10 |
| 6 | Meloxicam | Meloxicam | 369 | 995.6 | $2,253.49 |
| 7 | Gabapentin | Gabapentin | 343 | 746.5 | $5,607.43 |
| 8 | Celecoxib | Celecoxib | 323 | 805.2 | $10,233.28 |
| 9 | Pregabalin | Pregabalin | 290 | 308.5 | $6,501.26 |
| 10 | Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 273 | 273 | $4,530.61 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Philadelphia College Of Osteopathic Medicine
Graduation year
1993
Group/practice field
Alan J Kivitz Md Pc
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.